Stemtech (STEK) Current Leases (2021 - 2024)

Stemtech's (STEK) quarterly Current Leases came in at $22593.0 in Q2 2024, down 78.81% year-on-year from $106614.0 in Q3 2023, and down 45.13% quarter-over-quarter from $41174.0 in Q1 2024.

Stemtech (STEK) Current Leases (2021 - 2024) Analysis & Trends

Stemtech has disclosed Current Leases across 4 years of filings, most recently posting $22593.0 for Q2 2024.

  • Current Leases for Q2 2024 came in at $22593.0, down 78.81% year-over-year; the trailing twelve-month figure through Jun 2024 was $22593.0 (down 78.81% YoY), and the FY2023 annual result was $66866.0, down 43.84% from the prior year.
  • Current Leases came in at $22593.0 for Q2 2024 at Stemtech, down from $41174.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $119065.0 in Q4 2022 to a low of $22593.0 in Q2 2024.
  • The 4-year median for Current Leases is $70068.5 (2021), against an average of $73794.8.
  • Across the five-year window, Current Leases soared 113.59% in 2022 and slumped 78.81% in 2024, its largest moves.
  • Stemtech's Current Leases stood at $55745.0 in 2021, then jumped by 113.59% to $119065.0 in 2022, then slumped by 43.84% to $66866.0 in 2023, then sank by 66.21% to $22593.0 in 2024.
  • The last three Current Leases figures came in at $22593.0 (Q2 2024), $41174.0 (Q1 2024), and $66866.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 23.81 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 7.58 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 5.58 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Stemtech - - 354,677.00 -

Historic Data

Download Data
DateValue
Jun 30, 2024 22,593.00
Mar 31, 2024 41,174.00
Dec 31, 2023 66,866.00
Sep 30, 2023 83,836.00
Jun 30, 2023 106,614.00
Mar 31, 2023 108,376.00
Dec 31, 2022 119,065.00
Sep 30, 2022 62,018.00
Jun 30, 2022 65,359.00
Mar 31, 2022 80,621.00
Dec 31, 2021 55,745.00
Sep 30, 2021 73,271.00